Regeneron Pharmaceuticals
REGN
REGN
1,189 hedge funds and large institutions have $46.8B invested in Regeneron Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 133 funds opening new positions, 436 increasing their positions, 471 reducing their positions, and 199 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,189
Holders Change
-84
Holders Change %
-6.6%
% of All Funds
15.93%
Holding in Top 10
12
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-20%
% of All Funds
0.16%
New
133
Increased
436
Reduced
471
Closed
199
Calls
$1.15B
Puts
$1.01B
Net Calls
+$139M
Net Calls Change
+$166M
Top Buyers
| 1 |
Dodge & Cox
San Francisco,
California
|
+$789M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$318M |
| 3 |
Two Sigma Advisers
New York
|
+$202M |
| 4 |
BlackRock
New York
|
+$184M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$171M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.24B |
| 2 |
JPMorgan Chase & Co
New York
|
-$902M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$740M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$433M |
| 5 |
Amundi
Paris,
France
|
-$387M |
